erlotinib hydrochloride has been researched along with sta 9090 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (sta 9090) | Trials (sta 9090) | Recent Studies (post-2010) (sta 9090) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 133 | 13 | 129 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | sta 9090 (IC50) |
|---|---|---|---|
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | 1.3771 | |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | 1.8193 | |
| Endoplasmin | Homo sapiens (human) | 0.0377 | |
| Endoplasmin | Canis lupus familiaris (dog) | 0.01 | |
| Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | 0.0444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yaqub, F | 1 |
1 other study(ies) available for erlotinib hydrochloride and sta 9090
| Article | Year |
|---|---|
American Society of Clinical Oncology Annual Meeting 2013.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Docetaxel; Erlotinib Hydrochloride; Female; Humans; Imidazoles; Indoles; Lung Neoplasms; Male; Medical Oncology; Multicenter Studies as Topic; Oximes; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Societies, Medical; Sulfones; Sunitinib; Taxoids; Treatment Outcome; Triazoles; United States | 2013 |